Literature DB >> 15465812

Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH.

Ronit Rafaeloff-Phail1, Liyun Ding, Laura Conner, Wu-Kuang Yeh, Don McClure, Haihong Guo, Kimberlee Emerson, Harold Brooks.   

Abstract

AMP-activated protein kinase (AMPK) serves as an energy-sensing protein kinase that is activated by a variety of metabolic stresses that lower cellular energy levels. When activated, AMPK modulates a network of metabolic pathways that result in net increased substrate oxidation, generation of reduced nucleotide cofactors, and production of ATP. AMPK is activated by a high AMP:ATP ratio and phosphorylation on threonine 172 by an upstream kinase. Recent studies suggest that mechanisms that do not involve changes in adenine nucleotide levels can activate AMPK. Another sensor of the metabolic state of the cell is the NAD/NADH redox potential. To test whether the redox state might have an effect on AMPK activity, we examined the effect of beta-NAD and NADH on this enzyme. The recombinant T172D-AMPK, which was mutated to mimic the phosphorylated state, was activated by beta-NAD in a dose-dependent manner, whereas NADH inhibited its activity. We explored the effect of NADH on AMPK by systematically varying the concentrations of ATP, NADH, peptide substrate, and AMP. Based on our findings and established activation of AMPK by AMP, we proposed a model for the regulation by NADH. Key features of this model are as follows. (a) NADH has an apparent competitive behavior with respect to ATP and uncompetitive behavior with respect to AMP resulting in improved binding constant in the presence of AMP, and (b) the binding of the peptide is not significantly altered by NADH. In the absence of AMP, the binding constant of NADH becomes higher than physiologically relevant. We conclude that AMPK senses both components of cellular energy status, redox potential, and phosphorylation potential.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465812     DOI: 10.1074/jbc.M409574200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation.

Authors:  Rahul Agrawal; Emily Noble; Ethika Tyagi; Yumei Zhuang; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta       Date:  2015-02-03

2.  Occludin regulates glucose uptake and ATP production in pericytes by influencing AMP-activated protein kinase activity.

Authors:  Victor Castro; Marta Skowronska; Jorge Lombardi; Jane He; Neil Seth; Martina Velichkovska; Michal Toborek
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-18       Impact factor: 6.200

3.  Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver.

Authors:  Eun-Jeong Jung; Sung-Won Kwon; Byung-Hwa Jung; Seon-Hee Oh; Byung-Hoon Lee
Journal:  J Lipid Res       Date:  2011-07-14       Impact factor: 5.922

4.  Acetylation of TUG protein promotes the accumulation of GLUT4 glucose transporters in an insulin-responsive intracellular compartment.

Authors:  Jonathan P Belman; Rachel R Bian; Estifanos N Habtemichael; Don T Li; Michael J Jurczak; Abel Alcázar-Román; Leah J McNally; Gerald I Shulman; Jonathan S Bogan
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 5.  AMPK inhibition in health and disease.

Authors:  Benoit Viollet; Sandrine Horman; Jocelyne Leclerc; Louise Lantier; Marc Foretz; Marc Billaud; Shailendra Giri; Fabrizio Andreelli
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

6.  Deterioration of plasticity and metabolic homeostasis in the brain of the UCD-T2DM rat model of naturally occurring type-2 diabetes.

Authors:  Rahul Agrawal; Yumei Zhuang; Bethany P Cummings; Kimber L Stanhope; James L Graham; Peter J Havel; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta       Date:  2014-05-16

7.  'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition.

Authors:  Rahul Agrawal; Fernando Gomez-Pinilla
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

8.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

9.  Soluble thrombomodulin protects ischemic kidneys.

Authors:  Asif A Sharfuddin; Ruben M Sandoval; David T Berg; Grant E McDougal; Silvia B Campos; Carrie L Phillips; Bryan E Jones; Akanksha Gupta; Brian W Grinnell; Bruce A Molitoris
Journal:  J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 10.121

Review 10.  Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease.

Authors:  Nady Braidy; Gilles Guillemin; Ross Grant
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.